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Summary
Accurate, timely diagnosis is essential for the control, monitoring and eradication
of foot-and-mouth disease (FMD). Clinical samples from suspect cases are nor-
mally tested at reference laboratories. However, transport of samples to these cen-
tralized facilities can be a lengthy process that can impose delays on critical
decision making. These concerns have motivated work to evaluate simple-to-use
technologies, including molecular-based diagnostic platforms, that can be
deployed closer to suspect cases of FMD. In this context, FMD virus (FMDV)-
specific reverse transcription loop-mediated isothermal amplification (RT-LAMP)
and real-time RT-PCR (rRT-PCR) assays, compatible with simple sample prepa-
ration methods and in situ visualization, have been developed which share equiva-
lent analytical sensitivity with laboratory-based rRT-PCR. However, the lack of
robust ‘ready-to-use kits’ that utilize stabilized reagents limits the deployment of
these tests into field settings. To address this gap, this study describes the perfor-
mance of lyophilized rRT-PCR and RT-LAMP assays to detect FMDV. Both of
these assays are compatible with the use of fluorescence to monitor amplification
in real-time, and for the RT-LAMP assays end point detection could also be
achieved using molecular lateral flow devices. Lyophilization of reagents did not
adversely affect the performance of the assays. Importantly, when these assays
were deployed into challenging laboratory and field settings within East Africa
they proved to be reliable in their ability to detect FMDV in a range of clinical
samples from acutely infected as well as convalescent cattle. These data support
the use of highly sensitive molecular assays into field settings for simple and rapid
detection of FMDV.
Introduction
Foot-and-mouth disease (FMD) is a highly infectious
vesicular disease affecting both domesticated and wild
cloven-hooved animals. Caused by FMD virus (FMDV),
FMD affects over 100 countries worldwide, with disease
distribution roughly reflecting economic development
(Jamal and Belsham, 2013). Although the case-fatality rate
of FMD is generally below 5%, the disease can be
economically devastating: the annual global impact of FMD
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in terms of production losses and vaccination in endemic
regions alone is estimated between US$ 6.5 and 21 billion
(Knight-Jones and Rushton, 2013). Furthermore, endemic
infection represents a constant threat for FMD-free coun-
tries, with outbreaks incurring severe economic losses: for
example the UK 2001 outbreak is estimated to have cost
the national economy US$ 9.2 billion (FAO, 2002). Early
identification of FMDV in susceptible host populations is
essential to minimize the impacts of FMD. Confirmation of
FMD usually occurs at reference laboratories (OIE, 2012),
although transport of specimens to these facilities can delay
rapid real-time decision making. The development of tech-
nologies to provide rapid, sensitive and in situ FMD diag-
nosis is therefore an ongoing research priority.
A number of developments have been made in regard to
portable field assays for FMD diagnosis. Viral antigen
detection is possible using portable immunochromato-
graphic lateral flow devices (Ag-LFDs), which have equiva-
lent diagnostic sensitivity to the laboratory-based antigen
enzyme-linked immunosorbent assay (ELISA) (Ferris et al.,
2009, 2010). Although results are readable in as little as
10 min, Ag-LFDs have only been validated for use with
epithelial samples. Furthermore, low analytical sensitivity
restricts their usefulness to the acute clinical phase of FMD,
where epithelial samples contain high amounts of intact
virus particles. The World Organisation for Animal Health
(OIE) recommended real-time reverse transcription poly-
merase chain reaction (rRT-PCR) (Callahan et al., 2002)
has been transferred onto a portable platform, the Enigma
Field Laboratory (Enigma FL) (Enigma Diagnostics Lim-
ited, Salisbury, UK), which integrates silica paramagnetic
bead-based nucleic acid extraction, thermal cycling and
result reporting with minimal user intervention. Using wet
reagents, this platform showed high concordance to the
laboratory-based rRT-PCR (Madi et al., 2012).
Similar advancements have been made with reverse
transcription loop-mediated isothermal amplification (RT-
LAMP): a rapid nucleic acid amplification technique that
utilizes a strand-displacing polymerase, multiple primers
and autocycling under isothermal conditions. Simple
amplification and detection methods have been demon-
strated successfully for a previously published pan-seroty-
pic FMDV RT-LAMP assay (Dukes et al., 2006), by
combining water bath incubation with end-point molecular
LFD visualization (Waters et al., 2014), showing similar
sensitivity to laboratory-based rRT-PCR. Furthermore, the
development and commercial availability of portable fluo-
rometers, such as the Genie II (OptiGene Ltd., Horsham,
UK), allows for objective in situ real-time RT-LAMP (Craw
and Balachandran, 2012), improving upon subjective visual
detection measures such as turbidity and colour-change
dyes (Mori et al., 2001; Bearinger et al., 2011; Yamazaki
et al., 2013). An additional benefit of RT-LAMP is the abil-
ity to detect FMDV in samples without the requirement for
nucleic acid extraction, allowing simple sample preparation
methods, such as dilution in nuclease-free water to be
employed (Waters et al., 2014).
Currently published FMDV rRT-PCR and RT-LAMP
assays, even those proposed for use in field settings, have
been validated using ‘wet’ reagents, which contain tempera-
ture-sensitive enzymes incompatible for field deployment
or emergency stockpiling by countries normally free from
disease. Methods are now available to lyophilize reagents,
already tested in a number of LAMP (Boehme et al., 2007;
Mair et al., 2013) and PCR assays (Siegmund et al., 2005;
Aitichou et al., 2008; Helb et al., 2010; Takekawa et al.,
2012), with benefits including improved stability, storage
and transportability. This study describes the lyophiliza-
tion, laboratory validation and field testing in endemic
settings (Tanzania and Kenya) of a previously published
FMDV-specific rRT-PCR (Callahan et al., 2002; Madi et al.,
2012) and RT-LAMP assay (Dukes et al., 2006; Waters
et al., 2014). Field results were also compared against the
existing
Ag-LFD field-based diagnostic test (Ferris et al., 2009).
Materials and Methods
Laboratory work was carried out at The Pirbright Institute
(UK), unless stated otherwise.
Viruses and clinical samples for laboratory evaluation
To determine the effect of lyophilizing rRT-PCR reagents, a
comparison between wet and lyophilized reagents was per-
formed on a decimal dilution series of FMDV RNA in
0.1 lg/ll carrier RNA. Virus was obtained from clarified
bovine thyroid cell lysate infected with FMDV (O/UAE/2/
2003) and RNA extracted using the MagNA Pure LC Total
Nucleic Acid Isolation Kit (Roche, Burgess Hill, UK) as
manufacturer’s instructions.
Laboratory analysis of the Enigma FL was performed
using non-extracted archival clinical epithelial suspensions
from the field. Samples were obtained from the World
Reference Laboratory for FMD (WRLFMD, The Pirbright
Institute, UK) and consisted of the following: A (TAN/60/
2012), SAT1 (TAN/25/2012; TAN/22/2012) and one un-
typed (serotype not determined) sample (TAN/54/2012)
from which no virus could be isolated but was positive by
rRT-PCR. Archival field epithelial suspensions (also from
WRLFMD) were also used to evaluate the performance of
RT-LAMP and RT-LAMP combined with lateral flow detec-
tion (RT-LAMP-LFD) lyophilized reagents on clinical sam-
ples and consisted of: A (IRN/24/2012; TUR/7/2013; TUR/
4/2013), SAT1 (TAN/50/2012), SAT2 (TAN/14/2012; BOT/
15/2012) and Asia1 (TUR/2/2013). All above epithelial
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suspensions were prepared at 10% (w/v) in M25 phosphate
buffer (35 mMNa2HPO4, 5.7 mM KH2PO4, pH 7.6).
Archival experimental bovine sera (n = 19) and oeso-
phageal-pharyngeal (OP) fluid samples (n = 21) from cat-
tle infected with FMDV (isolate O/UKG/34/2001) were
used to expand on the work of Waters et al. (2014) and
create simple sample preparation protocols. In these trans-
mission studies, calves were either challenged directly (via
intradermolingual injection) or indirectly (via housing with
a donor) with FMDV O/UKG/34/2001. The samples tested
were collected daily from initial infection until 6 days post
challenge. This study had been previously approved by The
Pirbright Institute ethical review committee under the
Animal Scientific Procedures Act (ASPA) 1986.
Archival epithelial suspensions, used for laboratory anal-
ysis in East Africa (Sokoine University of Agriculture,
Morogoro, Tanzania), were from The Tanzania Veterinary
Laboratory Agency (TVLA, Dar es Salaam, Tanzania) and
were prepared in phosphate-buffered saline (pH 7.2). Sam-
ples represented the following serotypes and regions: O
(Musoma Rural; Tabora; Roya; Njombe; Mara; Kiliman-
jaro; Mtwara), A (Kagera), SAT1 (Dar es Salaam; Moro-
goro), SAT2 (Morogoro) and one un-typed sample.
Preparation of RNA standards for evaluation of
lyophilized RT-LAMP reagents
The limit of detection for the RT-LAMP and RT-LAMP-
LFD reagents was established using FMDV RNA standards.
The FMDV 3D region was amplified using previously
described primers 5ʹ-GGA CAG GAC ATG CTC TCA G-3ʹ
and 5ʹ-CAG GAA ACA GCT ATG ACT TTT TTT TTT TTT
TTT TTT TTG-3ʹ (Valdazo-Gonzalez et al., 2012) from
FMDV isolate O/UKG/35/2001. The subsequent PCR pro-
duct was purified using the Illustra GFX DNA/gel clean-up
kit (GE) and inserted into a pGEM-T vector (Promega,
Southampton, UK). Synthetic viral RNA transcripts were
produced by in-vitro transcription (MEGAscript,
Ambion, Thermo Fisher Scientific, Loughborough, UK)
followed by DNase digestion using TurboDNase
(Ambion). Transcripts were purified using MEGAclearTM
clean-up kit (Life TechnologiesTM, Thermo Fisher Scientific)
prior to quantification at A260 using a NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific). Transcripts
were diluted in nuclease-free water to give a decimal dilution
series of 106 to 101 copies, which were tested in duplicate.
Clinical samples for field evaluation
Field studies were carried out in Tanzania and Kenya, with
Ankole-cross and Zebu-cross cattle, where serum, OP fluid
and mouth/foot epithelium (where possible) samples
were collected across different stages of infection (acute, con-
valescent and recovered). Samples were also collected from
cattle in the affected herds which were clinically negative at
the time of sampling. In total, samples from 66 individual
cattle from 12 farms across East Africa were analysed in situ.
This work comprised eight cattle from two Maasai small
holdings from the Mvomero and Morogoro Rural Districts
(Morogoro Region, Tanzania, June 2014), 41 cattle from
seven small holdings located in the Serengeti District (Mara
Region, Tanzania, October 2014) and 17 cattle from three
farms in Nakuru County, Kenya (October 2013 and Decem-
ber 2014). Five of the cattle from Serengeti District, Tanzania
were sampled on two separate occasions, 6 days apart. Loca-
tions were chosen following reports of FMDV infection. For
Tanzania, field sampling was carried out with permission
from the Tanzania Commission for Science and Technology
(permit no. 2014-368-ER-2005-141) in accordance with
ASPA guidelines. For Kenya, sampling was carried out as
part of a training programme run by The European Com-
mission for the Control of Foot-and-Mouth Disease
(EuFMD). Samples were collected and processed as follows:
OP fluid: Was collected using a suitably sized probang
cup following OIE guidelines (OIE, 2012). OP fluid was
added neat to the mobile rRT-PCR platform and diluted
1 in 10 in nuclease-free water prior to analysis using RT-
LAMP and RT-LAMP-LFD (see below).
Serum: Cattle blood (10 ml) was collected from the
jugular vein using Vacutainer Plus Plastic Serum Tubes
(BD, Plymouth, UK). An aliquot was then centrifuged
using an E8 field-based centrifuge (LW Scientific) at
1400 g for 3 min at room temperature. Serum was
added neat to the mobile rRT-PCR platform and diluted
1 in 5 in nuclease-free water prior to RT-LAMP and RT-
LAMP-LFD (see below).
Epithelial tissue: Epithelial tissue surrounding ruptured
vesicles was collected from either the mouth or feet
using sterile forceps and was prepared using the
SVANODIP FMDV-Ag Extraction Kit (Svanova,
Boehringer Ingelheim, Uppsala, Sweden) according to
the manufacturer’s instructions. In brief, approximately
0.2 g of epithelial tissue was homogenized using the
sample extraction vial in 1 ml of sample buffer from the
SVANODIP FMDV-Ag LFD kit (Svanova). The homo-
genate was left to settle for 1 min and the supernatant
added neat to the mobile rRT-PCR and Ag-LFD plat-
forms, and processed as previously described prior to
RT-LAMP by dilution 1 in 5 in nuclease-free water
(Waters et al., 2014) (see below).
Real-time reverse transcription PCR
Laboratory-based OIE recommended rRT-PCR
The diagnostic ‘gold-standard’ one-step rRT-PCR was used
to target the conserved 3D region of the FMDV genome,
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using primers and probes as previously described (Callahan
et al., 2002). Reagents, parameters and thermal cycling
were as reported in Shaw et al. (2007). All reactions were
performed on nucleic acid extracted using the MagNA Pure
LC Total Nucleic Acid Isolation Kit (Roche) and MagNA
Pure LC automated platform as per manufacturer’s guideli-
nes (500 ll : 200 ll of sample and 300 ll of lysis/binding
buffer). Samples were assayed in duplicate on a bench top
real-time PCR machine (Stratagene Mx3005PTM; Agilent
Technologies, Stockport, UK).
Enigma field laboratory
rRT-PCR was performed as previously described (Madi
et al., 2012), with primers and probes as published in
Callahan et al. (2002). The platform integrates automated
nucleic acid extraction (from 500 ll sample), thermal
cycling and result reporting. Within field settings, the
Enigma FL was powered via a 15 V connection with vehicle
auxiliary. Lyophilized reagents were supplied by Enigma
Diagnostics Limited (Salisbury, Wiltshire), wet reagents
were as above.
Reverse transcription LAMP
Laboratory-based
Reverse transcription LAMP was performed as previ-
ously described (Waters et al., 2014) with the following
modifications. For wet reagents, the total reaction mix-
ture of 25 ll contained: 15 ll isothermal master mix
ISO-001 (OptiGene Ltd.) primers and concentrations as
per Dukes et al. (2006), 2 U AMV reverse transcriptase
(New England Biolabs, Hitchin, UK), 5 ll template and
made up to total volume with nuclease-free water. Lyo-
philized reagents were developed by OptiGene Limited,
using isothermal master mix ISO-001 with the addition
of primers (as above), stabilizing sugars and AMV. Lyo-
philized pellets were re-suspended with 15 ll of re-sus-
pension buffer, 5 ll sample and made up to 25 ll total
volume with nuclease-free water. RT-LAMP reactions
were run at 65°C for the manufacturer’s recommended
30 min on a Stratagene Mx3005PTM, followed by assay
inactivation at 85°C for 5 min. All samples were tested
in duplicate.
Fluorescence detection
ISO-001 contains an intercalating dye, enabling results to
be visualized using fluorescence collected at 1 min inter-
vals. A positive RT-LAMP reaction was indicated by an
exponential increase in fluorescence (dR) and the time to
positivity (TP) was defined when reactions reached a
threshold increase of dR 1000. To confirm that amplicons
were FMDV-specific, annealing analysis was performed on
RT-LAMP products using the Genie II (OptiGene Ltd.).
LAMP products were heated to 98°C, then cooled to 80˚C
ramping at 0.05°C/s. Anneal temperature (Ta) calculations
were automated using Genie Explorer v0.2.1.1 software
(OptiGene Ltd.). Samples were called positive if amplifi-
cation had occurred and the LAMP product annealed in
the FMDV amplicon-specific temperature range
87.5–89.5°C (88.5°C was the average Ta over 210 FMDV-
positive RT-LAMP reactions, with 98.55% of reactions
within 1°C).
RT-LAMP combined with lateral flow detection
The RT-LAMP-LFD assay was modified as previously
described by labelling the 50 termini of the inner LAMP
primers (FIP and BIP) (Waters et al., 2014). Results were
visualized using PCRD-2 lateral flow devices (Abingdon
Health, York, UK) as per manufacturer’s instructions. A
positive result was signified by the presence of two blue
bands (test and LFD control line); negative results were
indicated by a single band (the LFD control line). For all
images shown, the upper band represents the LFD control
line and lower band the test line with respect to the loading
pad at the bottom.
Field-based RT-LAMP and RT-LAMP-LFD
Mobile RT-LAMP and RT-LAMP-LFD were performed on
the Genie II using the lyophilized reagents as described
above. TP and Ta calculations were automated using Gen-
ie Explorer v0.2.1.1 software.
Antigen LFD
Six drops of homogenized epithelium from the SVANODIP
FMDV-Ag Extraction Kit were added to the SVANODIP
FMDV-Ag LFDs as previously published (Ferris et al.,
2009) and following manufacturer’s guidelines. LFDs were
incubated for 10 min at ambient temperature prior to
interpretation of results.
Statistical analysis
Cohen’s Kappa statistic (j) and the proportion of observed
agreement (Aobs) were used to measure the agreement
between diagnostic tests. All statistical tests were performed
in the statistical package R (R Core Team, 2014). Cohen’s
Kappa statistic (j) was interpreted as published in Landis
and Koch (1977).
Results
Laboratory evaluation of lyophilized rRT-PCR reagents
The wet Enigma reagents had been previously reported to
equal the limit of detection (between 10 and 100 viral gen-
ome copies) to the laboratory-based rRT-PCR (Madi et al.,
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2012). Lyophilization of reagents did not adversely affect
the performance of the assay, with both lyophilized and wet
reagents detecting down to 106 of the dilution series (data
not shown).
Archival epithelial suspensions were then used to
evaluate the full Enigma FL protocol (integrated nucleic
acid extraction and rRT-PCR) incorporating lyophilized
reagents for RNA extraction and rRT-PCR. Results
reported from the Enigma FL were comparable to
results gained using the OIE recommended rRT-PCR
performed on MagNA Pure extracted nucleic acid
(Table 1).
Laboratory evaluation of lyophilized RT-LAMP and RT-
LAMP-LFD reagents
The FMDV RT-LAMP wet assay has been previously
reported to have an analytical sensitivity of 101 copies/ll
(Dukes et al., 2006). Using RNA standards, equivalent
results were evident for lyophilized RT-LAMP and RT-
LAMP-LFD, consistently detecting down to 101 copies/ll
(Fig. 1). A TP value is not given for RT-LAMP-LFD due to
the interference of the fluorescein-labelled inner primer
(required for detection with LFDs) with the intercalating
dye used for RT-LAMP detection on the Genie II.
To evaluate the performance of RT-LAMP/RT-LAMP-
LFD lyophilized reagents on clinical samples, the previously
published protocol was used to prepare epithelial suspen-
sions (Waters et al., 2014) prior to direct use in RT-LAMP/
RT-LAMP-LFD. Samples represented five FMDV serotypes
(O, A, SAT1, SAT2 and Asia 1) and positive amplification
was observed in both assays in all five cases (data not
shown).
Determination of simple protocols for preparation of
clinical samples prior to RT-LAMP
Archival serum and OP fluid samples were used to expand
on the work of Waters et al. (2014) to create simple sample
preparation protocols. Samples were added to RT-LAMP
(wet reagents) following MagNA Pure nucleic acid
Table 1. Evaluation of lyophilized Enigma FL reagents using clinical
samples. Comparison between cycle threshold (CT) values for (a) rRT-
PCR performed on extracted RNA from epithelial suspensions using wet
reagents on a bench top real-time PCR machine; (b) rRT-PCR performed
on neat epithelial suspensions using lyophilized rRT-PCR reagents on
the Enigma FL
Serotype A
SAT1
SND Negative
Sample ID
TAN/60/
2012
TAN/25/
2012
TAN/22/
2012
TAN/54/
2012 Epithelium
(a) rRT-PCR (CT) 38.83 14.45 14.30 26.27 –
(b) Enigma Report Positive Positive Positive Positive Negative
SND, Serotype not determined.
Fig. 1. Limit of detection analysis for RT-LAMP and RT-LAMP-LFD. Data show (a) rRT-PCR CT values; (b) wet RT-LAMP TP values; (c) anneal analysis of
(b); (d) wet RT-LAMP-LFD results; (e) lyophilized RT-LAMP TP values; (f) anneal analysis of (e); (g) lyophilized RT-LAMP-LFD results. For rRT-PCR
□ repre-
sents CT values greater than the diagnostic threshold of CT <32 as reported by Shaw et al. (2007); for RT-LAMP
■ indicates that out of the identical
duplicates, one was positive and the other negative. For RT-LAMP-LFD, a positive result is indicated by the presence of two lines (lower test line and
upper control line), whereas a negative result only generates a single band (upper control line) with respect to the loading pad at the bottom (not
shown). [Colour figure can be viewed at wileyonlinelibrary.com]
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extraction or dilution in nuclease-free water (Table 2). As a
reference, nucleic acid extracted from all samples was
assayed using the OIE recommended rRT-PCR (Callahan
et al., 2002). High agreement was apparent between rRT-
PCR and RT-LAMP test results for sera following nucleic
acid extraction (j = 1.000, P = 0.000, Aobs = 1.000) and 1
in 5 dilution (j = 0.791, P = 0.000, Aobs = 0.895). Adding
sera neat to RT-LAMP resulted in an inhibitory effect with
no amplification seen in any of the rRT-PCR positive sam-
ples. Diluting sera one in five gave the optimum results for
RT-LAMP, therefore this dilution was used for subsequent
sera samples. Similar results were seen when comparing
rRT-PCR and RT-LAMP results for OP fluid following
MagNA Pure nucleic acid extraction (j = 0.859, P = 0.002,
Aobs = 0.952) and 1 in 5 dilutions (j = 0.577, P = 0.029,
Aobs = 0.857). When OP fluid was added to RT-LAMP
neat, 16/16 RT-LAMP negatives showed non-specific
amplification, which was still evident in 1 in 5 dilutions (as
determined by incorrect anneal temperatures). OP fluid
samples were therefore diluted 1 in 10 and compared to
rRT-PCR results (j = 0.741, P = 0.005, Aobs = 0.905). At
this dilution, results were optimal and no non-specific
amplification was evident. Subsequent OP fluid samples
were diluted 1 in 10 in nuclease-free water.
Detection of FMDV in endemic laboratory settings using
lyophilized rRT-PCR, RT-LAMP and RT-LAMP-LFD
assays
Fourteen archival epithelial suspensions, representing four
FMDV serotypes and 10 locations across Tanzania, were
used to compare the performance of portable diagnostic
systems on clinical samples (Genie II for RT-LAMP/RT-
LAMP-LFD, Enigma FL for rRT-PCR and Ag-LFDs) within
a local laboratory setting in a FMD endemic region. 100%
agreement was evident between RT-LAMP and RT-LAMP-
LFD assay results, which were both in high agreement with
rRT-PCR results (j = 0.759, P = 0.033, Aobs = 0.929)
(Fig. 2). Ag-LFDs showed reduced sensitivity with 3/12
Table 2. Comparative tables between the OIE recommended rRT-PCR and RT-LAMP. The following sample preparations were trialled for RT-LAMP
(wet reagents): (a) extracted RNA from sera; (b) neat sera; (c) 1 in 5 dilutions of sera; (d) extracted RNA from OP fluid; (e) neat OP fluid; (f) 1 in 5 dilu-
tions of OP fluid; (g) 1 in 10 dilutions of OP fluid. Data in tables represents the numbers of samples tested. Cohen’s Kappa statistic (j), P-value and the
proportion of observed agreement (Aobs) are reported
(a) Sera extracted RNA (b) Neat sera (c) Sera 1 in 5
RT-LAMP + RT-LAMP Total RT-LAMP + RT-LAMP Total RT-LAMP + RT-LAMP Total
rRT-PCR + 11 0 11 0 11 11 9 2 11
rRT-PCR 0 8 8 0 8 8 0 8 8
Total 11 8 19 0 19 19 9 10 19
j = N/A, P = N/A, Aobs = 1.000 j = 0.000, P = 0.500, Aobs = 0.421 j = 0.79, P = 0.000, Aobs = 0.895
(d) OP fluid extracted RNA (e) Neat OP fluid (f) OP fluid 1 in 5 (g) OP fluid 1 in 10
RT-LAMP + RT-LAMP Total RT-LAMP+ RT-LAMP Total RT-LAMP+ RT-LAMP Total RT-LAMP+ RT-LAMP Total
rRT-PCR + 16 1 17 5 12* 17 15 2 17 15 2 17
rRT-PCR 0 4 4 0 4* 4 1 3* 4 0 4 4
Total 16 5 21 5 16 21 16 5 21 15 6 21
j = 0.859, P = 0.002,
Aobs = 0.952
j = 0.137, P = 0.190,
Aobs = 0.429
j = 0.577, P = 0.029,
Aobs = 0.857
j = 0.741, P = 0.005,
Aobs = 0.905
*Groups in which at least one reaction showed non-specific amplification in RT-LAMP. rRT-PCR was performed on nucleic acid extracted using the
MagNA Pure and a diagnostic threshold of CT < 32 (Shaw et al., 2007) was used to distinguish between rRT-PCR positive and negative samples.
Fig. 2. Mobile detection of FMDV by rRT-PCR and RT-LAMP (100%
agreement was evident between RT-LAMP-LFD and fluorescence-based
RT-LAMP for these samples using the Genie II). Detection was
performed using 14 epithelial samples submitted to The Tanzanian
Veterinary Laboratory Agency (TVLA). Tests were performed in a local
laboratory at Sokoine University of Agriculture (SUA) in Morogoro,
Tanzania.
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samples called positive by RT-LAMP/RT-LAMP-LFD
reported as negative by Ag-LFD.
Detection of FMDV in situ using lyophilized rRT-PCR in
Kenya
Following successful evaluation of the Enigma FL on
archived field samples within a laboratory setting, prelimi-
nary field testing was performed in Nakuru, Kenya (Octo-
ber 2013) on 10 field samples (four blood; five epithelium;
one vesicular fluid) from six cattle, in two locations. In all
cases, mobile rRT-PCR results were consistent with clinical
observations (Table 3).
Detection of FMDV in situ using lyophilized RT-LAMP,
RT-LAMP-LFD and rRT-PCR assays
The Genie II and RT-LAMP/RT-LAMP-LFD protocols
devised in the laboratory were tested on 144 samples from
60 cattle (multiple samples taken from each animal,
Table 3. Initial Enigma FL rRT-PCR field testing results. Samples comprised blood, epithelium and vesicular fluid, collected from six cattle located in
Nakuru, Kenya. Ag-LFD results, performed on epithelial suspensions, are shown for comparison
Animal number
Location 1 Location 2
1 2 3 4 5 6
Temperature (°C) 38.8 39.6 36.5 Not tested 40.5 39.5
Lesion age 6–7 days 2–3 days None present 3 days 1–2 days 2–3 days
Samples collected Blood Blood Blood Epithelium Blood Epithelium
Epithelium Epithelium Epithelium
Vesicular fluid
Enigma FL (CT) Blood: CT 26 Blood: CT 18 Blood: CT 32 Epithelium: CT 30 Blood: CT 18 Epithelium: CT 16
Epithelium: CT –ve Epithelium: CT 31 Epithelium: CT 32
Vesicular fluid: CT 16
Ag-LFD Negative Positive Not applicable Negative Positive Positive
Fig. 3. In situ (a) RT-LAMP and (b) RT-LAMP-
LFD results for 144 East African samples. Cattle
were either acutely infected with FMD, dis-
played healing FMD lesions, were clinically
recovered from FMD or were FMD negative.
Black: positive result; white: negative result;
‘NT’: reaction not performed. Each column
represents one animal; rows represent sample
type. For some animals more than one epithe-
lial sample was tested, grey squares represent
a mix of positive and negative results.
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representing epithelium, serum and OP fluid) across 10
farms in East Africa (five cattle sampled on two occasions)
and compared to FMD clinical presentation. Of the cattle
that displayed approximately1–7 day old lesions, RT-LAMP
identified the presence of FMDV in 13 epithelial, 11 OP
fluid and 11 sera samples, the remaining samples were
negative, consistent with clinical observations (e.g. clear-
ance of viraemia). Of the cattle approximately 8–14 days
post initial lesion presentation, RT-LAMP identified FMDV
in eight epithelial, six OP fluid samples and one serum
sample; the remaining samples were negative, consistent
with disease progression. Of the clinically recovered cattle
(approximately 15+ days post initial lesion presentation),
RT-LAMP identified FMDV in 14 OP fluid samples (con-
sistent with delayed FMDV clearance), while all serum sam-
ples were negative. Of the 12 clinically negative cattle
sampled, all OP fluid and sera samples were negative (Fig.
3). High agreement was evident between RT-LAMP and
RT-LAMP-LFD for all sample types: sera (j = 0.837,
P = 0.000, Aobs = 0.947), OP fluid (j = 0.852,
P = 0.000, Aobs = 0.926) and epithelial samples (j = 0.646,
P = 0.123, Aobs = 0.957). All test results were consistent
with clinical observations.
For comparison, 34 of the samples assayed on RT-LAMP
and RT-LAMP-LFD above (13 epithelium; 17 OP fluid; 4
sera) were also assayed on rRT-PCR with the Enigma FL in
the field. Fair agreement was present between molecular
platforms: RT-LAMP and rRT-PCR (j = 0.635, P = 0.001,
Aobs = 0.853) and RT-LAMP-LFD and rRT-PCR (j =
0.781, P = 0.000, Aobs = 0.912) (Fig. 4). In addition, 23
epithelial samples were also assayed using Ag-LFDs, with
only slight agreement evident between both RT-LAMP and
Ag-LFD (j = 0.008, P = 0.486, Aobs = 0.522) and RT-
LAMP-LFD and Ag-LFD results (j = 0.095, P = 0.332,
Aobs = 0.565). Of 13 epithelial samples assayed by both
rRT-PCR and Ag-LFD, 8/13 results showed agreement,
with 5/12 rRT-PCR positive samples negative by Ag-LFD
(Appendix S1).
Four clinical samples (two epithelial and two vesicular
fluid) from two of the acutely infected cattle tested (tag
numbers 7804 and 7805) in the Serengeti District, Tanzania
were also shipped to WRLFMD for confirmation of FMD.
All four samples were confirmed positive for FMD using
rRT-PCR and were typed as serotype SAT1 by antigen ELI-
SAs (data not shown).
Discussion
Robust rapid diagnosis of FMD is essential for the effective
implementation of disease monitoring, control and eradi-
cation strategies, particularly during incursions into disease
free countries (Anderson, 2002). Historically where such
diagnostics have not been available, precautionary control
strategies including ‘slaughter on suspicion’ have been
implemented to bypass lengthy laboratory confirmation
and limit the potential size of the outbreak. However in the
case of the UK 2001 FMD outbreak, this approach led to
unnecessary culling, with retrospective analysis showing no
evidence of FMDV on 23% of premises designated as
infected (Ferris et al., 2001). This manuscript describes the
evaluation of lyophilized rRT-PCR and RT-LAMP assays to
rapidly detect FMDV directly from clinical samples in labo-
ratory and field settings.
Lyophilization of reagents had no impact on the perfor-
mance of either assay, with fluorescence-based RT-LAMP,
RT-LAMP-LFD and rRT-PCR maintaining comparable
analytical sensitivity to the equivalent ‘wet’ reagents and
laboratory-based rRT-PCR. However, a one log10 reduction
in the analytical sensitivity of wet RT-LAMP-LFD reagents
was evident comparatively to fluorescence-based RT-
LAMP. This was observed at the threshold of analytical
sensitivity and is therefore likely due to the quantity of
amplicon-latex bead complexes being too low for visualiza-
tion. Analytical sensitivity for this assay could be increased
if required (e.g. for samples with a low viral titer) by
extending the incubation period from the 30 min used in
this study to the 60 min previously reported by Waters
et al. (2014). Furthermore, simple sample preparation
methods for RT-LAMP and RT-LAMP-LFD (Waters et al.,
2014) were expanded further to include sera and OP fluid,
Fig. 4. Comparison between rRT-PCR (Enigma FL) and RT-LAMP (Gen-
ie II) on field samples tested in situ within Tanzania (Serengeti District
and Morogoro). (○) OP fluid samples; (●) epithelial samples. The linear
regression (R2 = 0.5207) between rRT-PCR CT and fluorescence-based
RT-LAMP TP is displayed.
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improving the diagnostic potential of the assays. This study
focuses on epithelium, OP fluid and serum samples, how-
ever, other sample types such as milk and swabs may also
be suitable for FMD diagnosis.
When deployed for field validation, both RT-LAMP and
rRT-PCR assays generated results consistent with clinical
observations, enabling virus to be detected across the FMD
clinical window from acute infection to delayed viral clear-
ance. In total, samples from 66 cattle across 12 endemic
field settings within East Africa were tested. The early
detection of FMDV was further substantiated by the data
from experimental samples, where positive results were
generated as early as 1 day post challenge. In all these stud-
ies, molecular assays consistently outperformed Ag-LFDs
by their ability to detect virus at lower concentrations and
in a greater number of clinical samples. However, Ag-LFDs
remain useful for confirmation of FMD positive animals
during the acute stage of clinical infection (using epithelial
samples) and were consistent with molecular assay results
under these circumstances.
Field validation highlighted a number of important fac-
tors to consider for future protocol design specific to the
use of RT-LAMP and RT-LAMP-LFD in situ. For example
appropriate sample collection is required to ensure (i) suffi-
cient amount of material is available for processing and (ii)
samples collected are not contaminated with soil (epithe-
lium) or blood/bolus (OP fluid). Although LAMP is consis-
tently reported to show increased tolerance to inhibitors
comparatively to PCR (Poon et al., 2006; Waters et al.,
2014), high levels of contaminants in samples are likely to
increase false-negative (reaction inhibition) or false-posi-
tive results (non-specific amplification). This is of particu-
lar concern when considering the ability of tests to confirm
FMD negative animals and the use of OP fluid samples
used to detect carrier status. Therefore, work is required to
further improve sample preparation methods for incorpo-
ration into field protocols.
During field validation, an initial period of time was
spent in local laboratories to confirm that reagents and
equipment were suitable for use post-air travel. For this, 14
archival epithelial suspensions were utilized. This process
was undertaken with local laboratory staff and highlighted
the additional potential of these technologies to improve
local diagnostic capacity within endemic settings. At pre-
sent, laboratories within these settings are often con-
founded by limited laboratory capacity (skilled personnel
and availability of technologies/consumables) and poor
transport links (maintenance of the cold chain). The provi-
sion of lyophilized reagents within disposable consumables,
in addition to simple reporting procedures, helps to address
these issues by (i) negating the need to order reagents and
consumables from multiple suppliers, (ii) simplifying
reagent storage requirements and (iii) minimizing user
intervention, thus opening up sensitive molecular tech-
nologies to unskilled staff. Combined, this would enable
countries to progress along the FAO progressive control
pathway for FMD eradication (Namatovu et al., 2013).
In conclusion, we present the development and evalua-
tion of lyophilized FMDV-specific rRT-PCR and RT-
LAMP assays, which both maintained similar analytical
sensitivity to the OIE recommended rRT-PCR. Both plat-
forms were highly compatible with field use, the Enigma
FL (rRT-PCR) through integration of RNA extraction,
and RT-LAMP through robust chemistry conditions
negating the requirement for RNA extraction. Therefore,
this study demonstrates an important transition for
FMDV-specific molecular assays into formats suitable for
field diagnostic use.
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